News Centre

EU Rules To Boost European Crowdfunding Platforms Agreed

Date 19/12/2019

• A single set of rules will apply to crowdfunding services in the EU, up to EUR 5 000 000 
• Strict rules to protect investors from financial losses 
• Member states responsible for authorising and supervising crowdfunding providers 

Nasdaq Advances Corporate Sustainability Leadership In 2019 - Reduces Carbon Footprint To Zero Through Offset Purchase Program

Date 19/12/2019

Nasdaq (Nasdaq: NDAQ) announced today its milestones achieved in 2019 to advance its environmental, social and governance (ESG) practices as part of its company-wide commitment to sustainability. Nasdaq’s ESG efforts were successfully reflected both in its work with corporate clients as well as within its own operations.

EBA Updates List Of CET1 Instruments

Date 19/12/2019

• The EBA has classified a new type of capital instrument as CET1;
• The EBA maintains and updates the CET1 list on a regular basis;
• The EBA shall be consulted ex-ante before including new capital instruments in the CET1 list;

Final Settlement Prices Determined For December MOEX Index Futures

Date 19/12/2019

Federal Reserve Board Issues Enforcement Action With Société Générale S.A. And Société Générale, New York Branch

Date 19/12/2019

The Federal Reserve Board on Thursday announced the execution of the enforcement action listed below:

Société Générale S.A., Paris, France, and Société Générale, New York Branch, New York, New York

Written Agreement (PDF) dated December 17, 2019

MOEX Trading Platform Up And Running On Kazakhstan Stock Exchange

Date 19/12/2019

In December 2019, Kazakhstan Stock Exchange (KASE) has successfully gone live with its stock market on MOEX’s ASTS+, the trading and clearing platform with central counterparty.

ImmuPharma lists on Euronext Growth Brussels - Through This Dual Listing, ImmuPharma, Which Is Already Listed On AIM, Aims To Diversify And Enlarge Its Shareholder Base In Continental Europe

Date 19/12/2019

ImmuPharma PLC, (LSE AIM: IMM – Euronext Growth: ALIMM) a specialist drug discovery and development company, today began trading on Euronext Growth Brussels. On the day of listing in Brussels, ImmuPharma’s market capitalisation stood at approx. €33.37 million. The Company did not issue any new shares.

EBA: Consultation Paper on draft RTS On Revised Identified Staff For Remuneration Purposes (EBA/CP/2019/16 )

Date 19/12/2019

The European Banking Authority (EBA) launched today a public consultation on its draft Regulatory Technical Standards (RTS) on the criteria to identify all categories of staff whose professional activities have a material impact on the institutions’ risk profile (“risk takers”). The aim of these standards is to define and harmonise the criteria for the identification of such staff and to ensure a consistent approach across the EU. The suggested identification process is based on a combination of qualitative and quantitative criteria. The consultation runs until 19 February 2020.

Oslo Børs: Highest Ever Dividends

Date 19/12/2019

Never before have companies listed on Oslo Børs returned so much money to shareholders in the form of dividends as in 2019.

The Tel Aviv Stock Exchange – Annual Review For 2019 And Outlook Into 2020

Date 19/12/2019

• The TA-35 Index, which has risen 15% this year, outperformed the world's equity indices that gained an average of 9%; the TA-90 Index rose by 39% this year hitting an all-time record
• The leading indices in the five years 2015-2019 were the TA-Technology and TA-Real Estate indices, which cumulatively gained 143% and 122%, respectively
• 7 new companies joined TASE this year, raising in excess of NIS 3 billion
• During the years 2017-2019, 35 new companies joined TASE, raising a total of NIS 8.1 billion
• NIS 11.7 billion was raised on the equities market – 75% more than the amount raised last year
• NIS 65.5 billion was raised in corporate bond offerings to the public and institutions and a further NIS 3.3 billion was raised in structured bond offeringsThis year, TASE became a public company by means of a first-of-its-kind IPO, using the “Tel Aviv-Global" model – a global offering on the Tel Aviv Stock Exchange
• Ittai Ben Zeev, the Tel Aviv Stock Exchange's CEO: “the Israeli economy's biggest missed opportunity is that, in less than a decade, $112 billion has “evaporated" from Israel due to companies having been sold rather than being turned into independent companies. It's high time that not just Bob Smith from Minnesota, but also Yael Cohen from Tel Aviv, profits from the success of Israeli innovation. The model of making a global offering in Tel Aviv enables Israeli companies and particularly high-tech companies, to benefit from an innovative capital-raising model and from exposure to international investors, while also ensuring that larger portions of the Israeli public will be partners in the growth of the economy".